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ABSTRACT: Nanoparticles interfere with protein amyloid formation.
Catalysis of the process may occur due to increased local protein
concentration and nucleation on the nanoparticle surface, whereas tight
binding or a large particle/protein surface area may lead to inhibition of
protein aggregation. Here we show a clear correlation between the
intrinsic protein stability and the nanoparticle effect on the aggregation
rate. The results were reached for a series of five mutants of single-chain
monellin differing in intrinsic stability toward denaturation, for which a
correlation between protein stability and aggregation propensity has
been previously documented by Szczepankiewicz et al. [Mol. Biosyst.
2010 7 (2), 521−532]. The aggregation process was monitored by
thioflavin T fluorescence in the absence and presence of copolymeric
nanoparticles with different hydrophobic characters. For mutants with a
high intrinsic stability and low intrinsic aggregation rate, we find that amyloid fibril formation is accelerated by nanoparticles. For
mutants with a low intrinsic stability and high intrinsic aggregation rate, we find the oppositea retardation of amyloid fibril
formation by nanoparticles. Moreover, both catalytic and inhibitory effects are most pronounced with the least hydrophobic
nanoparticles, which have a larger surface accessibility of hydrogen-bonding groups in the polymer backbone.
■ INTRODUCTION
The formation of well-defined cross-β-sheet structures known
as amyloid fibrils is now considered a generic feature of
polypeptides.
1,2 Some of the proteins with a high propensity to
form such structures are associated with severe diseases such as
Alzheimer's, Parkinson's, diabetes type 2, etc.
3 The propensity
of a given peptide to form amyloid aggregates is strongly
influenced by the nature of the amino acid sequence as well as
the properties of the environment.
4,5 The amino acid sequence
may favor or disfavor aggregation due to charge, hydro-
phobicity, spacing, and patterns of polar and nonpolar residues
as well as secondary structure propensity.
5−10 The aggregation
propensity of globular proteins is often inversely related to the
stability of the native state.
6 Destabilization of the native state is
recognized as a primary mechanism for familial or sporadic
mutations to exert their pathogenic potential in amyloid
diseases.
10−13 Amino acid substitutions that destabilize the
native state increase the aggregation propensity by increasing
the population of unfolded species.
11,14
Protein adsorption is the first event that occurs when a
foreign material is introduced into a physiological fluid.
15
Proteins are highly surface active and have a high affinity for
surfaces.
15,16 Adsorption is usually fast and depends on the
balance of a number of enthalpic and entropic changes, such as
partial dehydration of the protein or sorbent surface,
redistribution of charged groups on the surface, and conforma-
tional changes in the protein. The contribution of each process
will depend on the nature of the protein and surface.
17 The
adsorption of globular proteins on a solid surface is related to
the stability of its native structure. Proteins with high structural
stability act like hard particles, and the adsorption is mainly
governed by hydrophobic and electrostatic effects. In the case
of proteins with low structural stability, the ability of structural
arrangement on the particle surface is an extra factor for protein
adsorption, allowing attractive interactions with hydrophilic and
oppositely charged surfaces.
18 Protein adsorption can have
diverse effects on the conformation of the protein. Once more,
the extent of conformational modification would depend on the
stability of the native structure. Adsorption may be with little
structural change or cause denaturation depending also on the
character of the surface.
16,19−21
The stability of the native state of a protein will hence govern
not only the propensity to form amyloid fibrils but also the
interaction between the protein and surfaces. Globular proteins
tend to minimize the exposure of their hydrophobic groups, but
the protein exterior is often partially hydrophobic. Dehydration
of hydrophobic parts of the protein and surface is driven by a
gain in entropy and therefore favors adsorption.
17,22,23
Modifications that lead to increased exposure of the protein
hydrophobic core will thus favor adsorption on a hydrophobic
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to suitable surfaces. Therefore, a mutation which reduces the
solubility of a protein modifies the strength of the protein−
particle interaction.
24
The fibrillization process of amyloid proteins can be affected
by several factors, including solution properties such as the
ionic strength, pH, temperature, presence of chaperones,
peptide inhibitors, etc.
25−31 The presence of foreign surfaces
in the system, in the form of engineered nanoparticles, shows a
profound effect on the formation of amyloids.
30,32−36 For
example, copolymeric nanoparticles accelerate the fibrillization
of β2-microglobulin by promoting nucleation on the particle
surface.
36 On the other hand, the same nanoparticle type
produces the opposite effect on β-amyloid peptide (Aβ)
32 and
islet amyloid polypeptide (IAPP).
37 In those cases the
retardation of the process was explained by the depletion of
monomers from solution due to the adsorption on the particle
surface. Dual behavior was observed for amino-modified
polystyrene particles, which accelerate or retard the amyloid
formation of Aβ peptide depending on the relative concen-
tration of peptide and nanoparticle surface.
38 Diverse studies
have shown the effect of other nanoparticles, such as Teflon or
fluorinated polymeric nanoparticles, on the conformation of β-
amyloid. Shifting of the secondary structure toward a more β-
sheet rich structure upon binding on the particle surface
enhances the risk of forming amyloid fibrils.
33,34 However, no
systematic study on the effect of mutations on the interaction
between nanoparticles and amyloid proteins is found in the
literature.
In this work we have explored the fibrillization kinetics of
single-chain monellin mutants in the presence of model
copolymeric nanoparticles of N-isopropylacrylamine
(NiPAM) and N-tert-butylacrylamide (BAM) with different
ratios between the monomers. Monellin (MN) is a sweet-
tasting plant protein composed of two subunit chains. This
protein shows amyloidogenic properties and forms amyloid
fibrils under certain conditions.
39,40 Recombinant single-chain
MN (scMN), with MNA (subdomain A) covalently linked to
MNB (subdomain B), has retained sweetness and increased
stability against thermal denaturation.
41 The structures of
monellin and scMN superimpose, with MNA forming three β-
strands and MNB forming two β-strands separated by an α-
helix. The five scMN mutants studied here were retrieved from
a phage display library on the basis of their surface activity. All
modifications are confined to subdomain A and alter the
electrostatic charge of subdomain A or the hydrophobic
interactions between the subdomains.
The results show that the fibrillization of the mutants is
affected by the presence of particles, but the type and extent of
the effect vary depending on the mutation in a systematic
manner. Thus, the amino acid sequence and, therefore,
physicochemical characteristics of mutants have an effect on
both the fibrillization pattern and its modulation by nano-
particles. This indicates the existence of different modes of
interaction between the particle and protein.
■ MATERIALS AND METHODS
Production and Purification of Single-Chain Monellin
Mutants. Production and purification were performed as described
elsewhere.
42
Particle Preparation. Nanoparticles were kindly supplied by Dr.
Iseult Lynch, University College Dublin. NiPAM/BAM copolymer
particles were synthesized in sodium dodecyl sulfate (SDS) micelles as
previously described.
36 Particles were produced at different como-
nomer ratios (85:15 and 50:50 NiPAM/BAM) and with a diameter of
40 nm (at 37 °C). After polymerization, the particles were dialyzed
against Milli-Q H2O for at least 14 days with daily changes of H2Ot o
eliminate any trace of SDS as corroborated by proton NMR. Particles
were lyophilized and stored until use. Stock solutions were prepared
by dissolving particles in ice-cold Milli-Q water.
Thioflavin T Fluorescence Assay. Aggregation kinetics were
monitored using thioflavin T (ThT; Calbiochem) as a probe. The
fluorescence signal was measured at regular intervals using a Molecular
Devices SpectraMax M2 microplate reader (Sunnyvale, CA) with
excitation and emission at 440 and 480 nm, respectively. Each
experimental point is an average of the fluorescence signal of six wells
containing aliquots of the same solution. Samples for aggregation
experiments were prepared as follows. Lyophilized protein was
dissolved in 10 mM sodium phosphate buffer, 0.02% NaN3, pH 3.5,
to a concentration of 1 mg/mL. The solution was vortexed and
centrifuged to eliminate any solids. After dilution in the same buffer,
the solution was aliquoted in a 96-well black fluorescence plate,
NUNC 96 MicroWell black polypropylene plate, and ThT stock
solution and particle stock solutions were added. Typical concen-
trations in these aggregation experiments are 0.20 mg/mL protein and
18 μM ThT. The nanoparticle concentration ranges from 0.9 to 30
μg/mL (from 8.1 to 270 pM as previously calculated
32). The plates
Figure 1. Fibrillization kinetics of single-chain monellin (scMN parent and mutants) at 37 °C monitored by temporal development of ThT
fluorescence at different 85:15 NiPAM/BAM nanoparticle concentrations: (black squares) 0, (blue circles) 0.9, (blue-green triangles) 1.8, (green
inverted triangles) 3.5, (yellow left-pointing triangles) 7, (red right-pointing triangles) 15, and (purple hexagons) 30 μg/mL (8.1−270 pM). The
concentration of scMN is 0.2 mg/mL (17.5−18.7 μM depending on the mutant). The lines represent the best fittings to eq 1.
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incubator/shaker with an orbit of 3 mm (Labnet International,
Berkshire, U.K.). Aggregation curves were normalized to the maximum
intensity for each mutant to facilitate comparison between mutants. A
sigmoidal fit was used to obtain the kinetic parameters of the process.
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where y is the fluorescence intensity at time t, y0 and ymax are the initial
and maximum fluorescence intensities, respectively, t1/2 is the time
required to reach half the maximum intensity, and k is the apparent
first-order aggregation constant. The lag time is defined as lag time =
t1/2 − 2/k.
Transmission Electron Microscopy. Negative-staining trans-
mission electron microscopy (TEM) samples were prepared as
follows. A 10 μL volume of sample was applied to a formwar/
carbon-coated grid for 2 min and blotted with filter paper. The sample
was stained with 2% uranyl acetate aqueous solution for 2 min and
blotted. Finally, the grids were washed twice with filtered (0.2 μm)
water and air-dried. Images were obtained using a JEOL 2000
transmission electron microscope operating at 80 V. Intensity
measurements between replicates typically deviate less than 10%.
■ RESULTS
Fibrillization experiments of the parent protein scMN and the
mutants were performed in the absence and presence of 85:15
and 50:50 NiPAM/BAM particles at different concentrations.
The monomer ratio of the particles establishes their
physicochemical properties, such as the phase transition
temperature and hydrophobic character. The fibrillization
reaction was monitored by means of a ThT fluorescence
assay. ThT is a dye that specifically binds amyloid aggregates,
and upon binding, the quantum yield of fluorescence increases,
thus allowing quantitative assessment of the presence of fibrillar
species. As reported previously,
42 each mutant shows a different
aggregation tendency (Figure 1). The parent protein presents
no aggregation during the length of the experiment (up to 4
days) in the presence or absence of nanoparticles, while the
formation rate differs for all the mutants. All of the aggregation
experiments exhibit the characteristics of a typical amyloid
fibrillization profile: a sigmoidal curve with an initial lag phase,
where no increase of fluorescence is observed because no
amyloid aggregates are formed, a rapid elongation phase, where
the fluorescence intensity increases as the aggregates form, and
an equilibrium plateau phase, where the maximum fluorescence
remains stable. Self-assembly of amyloid has the appearance of
a nucleation-dependent mechanism with a characteristic
sigmoidal reaction profile as shown by scMN.
31,43,44 The lag
time is defined as the time required to reach a certain fraction
of monomer in fibrillar form. After the lag time, the aggregation
proceeds rapidly, showing a sharp increase of fluorescence
intensity in the ThT assay.
A different response to the addition of the particles is
observed for each mutant. The aggregation rates are affected in
different directions depending on the mutant character. There
are also differences (significant and persistent between
experiments) between the values of the equilibrium plateau in
the presence or absence of particles. To facilitate the
comparison between fibrillization rates, the curves are
normalized (see the Materials and Methods). In general, the
effect of 85:15 NiPAM/BAM nanoparticles is more pro-
nounced than for the 50:50 NiPAM/BAM nanoparticles. For
that reason, we will mainly focus here on the effect of 85:15
nanoparticles, while the aggregation kinetics in the presence of
50:50 nanoparticles for all the mutants can be found in the
Supporting Information (Figure S1).
Figure 1 shows the fibrillization traces for the scMN parent
and mutants in the presence of different concentrations of
85:15 NiPAM/BAM particles. Figure 2A shows the lag times
(plotted as the ratio of the lag time at each particle
concentration and the lag time in the absence of particles) as
a function of the nanoparticle concentration. The parent scMN
shows no fibrillization for 6000 min, and no nanoparticle effect
is observed in that time range. In the case of scMN13 and
scMN14, the presence of the particles accelerates the
fibrillization process. In both cases, the reaction kinetics in
the absence of particles is quite slow and there is not a
consistent pattern between the particle concentration and
shortening of the lag time. For the rest of the mutants,
scMN10, scMN11, and scMM12, the presence of the particles
increases the lag time. In these cases there is a clear correlation
between the concentration and the rate of fibrillization; the
higher the concentration of particles, the slower the
fibrillization process. The fibrillization of scMN10 and
scMN14 is the most sensitive to particle addition. Just a
small amount of particles, 1.8 μg/mL, produces a significant
variation in the lag phase. Acceleration of the fibrillization after
the addition of particles is observed for the most stable mutants
(scMN13, scMN14) for which fibrillization in the absence of
the particles is quite slow. On the other hand, for the mutants
Figure 2. (A) Ratio of lag times in the presence and absence of nanoparticles versus particle concentration. (B) Lag time versus thermal denaturation
midpoint, Tm, for the different mutants.
42 The straight line indicates the observed linear correlation. Key: (■) scMN10, (●) scMN11, (▲) scMN12,
(◆) scMN13, (▼) scMN14, and (★) parent scMN.
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process is slowed in the presence of the particles.
The formation of the fibrils in the presence or absence of
particles was confirmed by transmission electronic microscopy
(Figure 3). Samples were prepared after 4000 min of incubation
to ensure formation of fibrils in the presence and absence of
nanoparticles. Amyloid-like aggregates were found in all cases
except for the parent protein. For the case of scMN10, it also
appears that the presence of particles changes the final
morphology of the fibrils and leads to the formation of shorter
and stickier fibrils.
■ DISCUSSION
The fibrillization process of the single-chain mutants of the
sweet-tasting protein monellin is profoundly affected by the
presence of polymeric nanoparticles. This set of mutants
constitutes an interesting model system to understand protein
characteristics and its effect on fibrillization. The observed
variation of behavior in the nanoparticle−scMN system arises
from the physicochemical characteristics of the mutants and
how these properties govern the adsorption of the monomeric/
oligomeric species on the particle surface. The conformational
stability of each mutant affects both the rate of the fibrillization
process relative to the parent protein and the effect of
nanoparticles reporting on specific interactions between the
protein and the nanoparticle surface.
As reported before,
42 all the mutants are folded proteins, but
their far-UV circular dichroism spectra differ from that of the
parent protein. The parent protein has five β-strands and one
α-helix and a predominantly β-sheet spectrum, while for the
mutants the helical segment is more apparent in the spectra.
The near-UV CD spectra indicate a higher conformational
flexibility for the mutants than for the parent protein.
Moreover, thermal denaturation studies show that the mutants
are less stable than the parent protein (Figure 2B).
42 The
increased exposure of aggregation-prone segments, which are
protected in the parent protein, favors the aggregation into
amyloid fibrils. Residues that are changed or missing in all
mutants are in the A chain in close contact with the B chain.
Those residues seem to establish important interactions
between the two chains. Weakening these interactions may
lead to the destabilization of the protein and the increase of
aggregation-prone segments.
42
Figure 2B shows the correlation found between the lag times
of fibrillization and the apparent melting temperature. Clearly,
as the stability against thermal denaturation increases, the lag
time for fibrillization increases as well. This indicates that the
most stable proteins have a lower tendency to unfold and
aggregate into amyloid fibrils. This was corroborated with the
calculation of the aggregation propensity of each mutant based
on the amino acid sequences.
42 A similar correlation between
stability and fibrillization time was reported previously for




The effect on fibrillization is also dependent on the type of
nanoparticle used. The 50:50 NiPAM/BAM nanoparticles have
a lower effect on scMN fibrillization than the most hydrophilic
85:15 NiPAM/BAM nanoparticles. Similar results were
obtained previously for the aggregation of β2-microglobulin
36
and Aβ peptide.
32 These studies indicate a stronger interaction
between protein and particles that have more accessible
hydrogen bond groups. The higher propensity to form
hydrogen bonds for the 85:15 particles may explain why
these particles are more potent in disturbing the fibrillization
process of single-chain monellin.
The nanoparticle effect is observed not only in the
fibrillization kinetics, but also on the final fibrillar material.
For example, in the case of scMN10, the morphology of the
fibrils differs from the morphology of the fibrils formed in the
absence of particles. This observation may indicate an influence
of nanoparticles on the packing and formation of the mature
fibrils.
43,45 These differences in morphology in the presence or
absence of particles can be the reason for the different
equilibrium values of the ThT fluorescence intensity. Changes
in structure and packing can enhance or decrease the binding,
and therefore fluorescence signal, of ThT, resulting in different
plateau values.
45
The different kinetic effects observed cannot be explained by
a kinetic competition between the two processes of amyloid
fibril formation and nanoparticle−protein complex formation.
In a kinetic competition situation, the most affected mutant
should be the one with the longest lag phase, which would
allow a longer interaction between the oligomeric, prefibrillar
species and the nanoparticles.
26 However, in the case of scMN,
two mutants exhibit the biggest effect by the addition of the
particles, scMN10, which has the fastest intrinsic aggregation
kinetics, and scMn14, which has the slowest. Besides, this
hypothesis would not explain acceleration of the fibrillization
process. The observed dual behavior suggests that the
interaction with the nanoparticle occurs at the monomer and
oligomer levels.
During the lag phase for fibrillization, soluble oligomers of
different sizes are formed and are in equilibrium with
monomeric species. Amino acid replacements that destabilize
Figure 3. Negative-staining TEM images for samples prepared in the absence or presence of 30 mg/mL (270 pM) 85:15 NiPAM/BAM
nanoparticles for parent and mutant single-chain monellin. The scale bar indicates 200 nm.
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2
As we reported before, a correlation between the aggregation
propensity and the stability of the mutants is found.
42 Protein
destabilization causes an increase in the population of partially
unfolded conformations that expose the aggregation-prone
regions and increase the probability of intermolecular
interactions.
9 In that context, the population of oligomers
during the lag phase for the more stable mutants scMn14 and
scMn15 should be lower than for the most unstable mutants
scMn10, scMN11, and scMN12.
The observed nanoparticle effect on single-chain monellin
fibrillization can be divided into two categories, acceleration or
retardation of the fibrillization process caused mainly by a
modification of the lag time (Figure 2).
Acceleration of the fibrillization in the presence of nano-
particles for the most stable mutants (Figure 2B) can be
explained by taking into account the physicochemical character-
istics of the protein that govern the interactions with the
nanoparticle surface. It is well-known from the studies of
protein adsorption on flat surfaces that the physicochemical
characteristics of the protein strongly affect the adsorption
process. For example, it is widely considered that “soft proteins”
would interact strongly with surfaces due to the gain of entropy
coming from the changes in conformation upon adsorption.
More flexible proteins can form many noncovalent interactions
with the surface by modification of the secondary structure,
increasing the strength of the adsorption and the residence time
on the surface. In general, changes in the protein conformation
are the main driving forces in the adsorption of protein on
prohibited surfaces, i.e., hydrophilic or bearing the same charge
as the protein. “Hard proteins” retain the secondary structure,
and therefore, the adsorption depends on the surface−surface
interactions, either hydrophobic or electrostatic interactions. In
the case of noncharged surfaces, the main drive of the
interaction is the gain of entropy by the release of hydration
water on the protein and particle surface.
15,23 For scMN14 and
scMN15, the addition of particles causes the adsorption on the
particle surface of monomers and oligomers in a weak fashion
without loss of their structural conformation. Therefore, the
proteins would be concentrated in a reduced volume but would
keep their amyloidogenic propensity. This crowding effect
would favor the nucleation and therefore speed up the
fibrillization process (Scheme 1). Similar effects were observed
in the case of β2-microglobulin, where we hypothesized that the
nanoparticle promotes nucleation and consequently fibril
formation.
36 Similar crowding effects have been reported
previously
7 where the fibrillization kinetics is accelerated by
raising the local concentration of an amyloid protein in the
presence of dextran.
Retardation of the fibrillization due to the presence of
nanoparticles for the less stable mutants is observed (Figure
2B). A similar effect was reported for the fibrillization of diverse
amyloid proteins (Aβ protein
32,38 and IAPP
37) in the presence
of nanoparticles, and depletion of the monomer from the bulk
was proposed as a possible cause. However, in this case, the
analysis of the ratio between the nanoparticle surface and the
maximum protein surface coverage discards a relevant effect of
nanoparticles at the scMN monomer level. scMN has an
approximate cross-section area of (5−12) × 10−18 m2.
Therefore, a single particle 40 nm in diameter (surface area 5
× 10−15 m2) can accommodate a maximum of 1000
nondenaturated proteins arranged in a single layer. Taking
into account the total surface area in solution exposed by the
particle at the highest concentration used (0.84 m2), only 2% of
the protein molecules are needed to cover the particle as a
single layer. Multiple layers can be formed, but this implies a
high local concentration of proteins that will enhance
fibrillization instead of hinder it. Increases of 5−10-fold in lag
times are observed for the highest particle concentration.
Correlations between lag time and protein concentration have
been reported for several systems.
46,47 Even assuming a strong
scaling factor, a decrease of 2% in concentration may lead to
only a marginal increase in lag time. Therefore, we postulate
that nanoparticles interact with early aggregates of scMN,
disturbing their growth into fibrils. This is not unexpected if we
consider that the population of oligomers for those unstable
mutants must be significantly higher than for more stable ones
due to stronger intermolecular interactions (see above).
Nanoparticles can deplete and/or dissolve prefibrillar oligomers
or small fibrillar aggregates, which are metastable and present in
relatively small populations (Scheme 1). To obtain an
inhibitory effect by depletion, nanoparticles must bind
preferentially lowly abundant oligomeric species in a way that
blocks further growth. Adsorption of abundant intermediate
oligomers must imply destabilization and dissolution of
oligomers into monomers or oligomers of smaller size. As
explained before, “soft” flexible proteins interact strongly with
surfaces since they can establish many noncovalent interactions,
resulting in long resident times. If the nanoparticle−monomer
interactions are stronger than the monomer−monomer
interactions, the oligomers adsorbed on the particle surface
will dissolve into monomers and/or oligomers of smaller size.
Overall, the equilibrium between monomers and oligomers will
be shifted toward the monomer side due to the presence of the
particles. This implies an elongation of the lag phase and
therefore a retardation of the whole aggregation process.
■ CONCLUSIONS
Two factors control the effect of nanoparticles on amyloid
formation: first the surface chemistry of the nanoparticles and
second the protein intrinsic stability. Those factors determine
the specific interactions between nanoparticles and protein
which lead to dual effects on the fibrillization process of
amyloid proteins. Polymeric nanoparticles interact at both the
monomer and oligomer levels, acting either as microreactors or
as destabilizing agents, which causes acceleration or retardation
of amyloid formation.
Scheme 1. Different Modes of Nanoparticle−Protein
Interactions and Their Effects on the Fibrillization Rate
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Figure S1 showing the fibrillization kinetics of different scMN
mutants in the presence and absence of different concentrations
of 85:15 and 50:50 NiPAM/BAM nanoparticles. This material
is available free of charge via the Internet at http://pubs.acs.
org/.
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